Summit Therapeutics Publishes Preclinical Data second generation utrophin modulator

Views: 414

Reply to This

Replies to This Discussion

Journal of Human Molecular Genetics

Second-generation compound for the modulation of utrophin in the therapy of DMD

After listening to the Summit conference call this has exciting potential for all kids with DMD.

Jeff Harvey Sr.

Hopefully it won't take decades until our children can benefit from the therapy.

You are right Peter . Only thing which bothers every parent is clinical trials are taking decades .

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service